Elevance Health Inc (NYSE: ELV) (previously known as Anthem) remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members.
Elevance Health's (NYSE:ELV) short percent of float has fallen 4.4% since its last report. The company recently reported that it has 2.08 million shares sold short, which is 0.87% of all regular shares that are available for trading.
B of A Securities upgraded its rating of Elevance Health (NYSE:ELV) to Buy with a price target of $575.00, changing its price target from $535.00 to $575.00. Shares of Elevance Health are trading up 1.5% over the last 24 hours, at $496.71 per share.
Elevance Health (NYSE:ELV) has observed the following analyst ratings within the last quarter: